Alliancebernstein L.P. Atri Cure, Inc. Transaction History

Alliancebernstein L.P.

$261 Billion
Q1 2025

A detailed history of Alliancebernstein L.P. transactions in Atri Cure, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 3,676,849 shares of ATRC stock, worth $108 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,676,849

Previous 3,835,449 4.14%

Holding current value

$108 Million

Previous $117 Million 1.2%

% of portfolio

0.05%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$30.4 - $42.4 $4.82 Million - $6.72 Million	-158,600 Reduced 4.14%	3,676,849 $119 Million
Q4 2024 Feb 12, 2025	SELL	$27.02 - $38.2 $3.7 Million - $5.23 Million	-136,999 Reduced 3.45%	3,835,449 $117 Million
Q3 2024 Nov 14, 2024	SELL	$20.34 - $29.5 $4.73 Million - $6.86 Million	-232,531 Reduced 5.53%	3,972,448 $111 Million
Q2 2024 Aug 14, 2024	BUY	$19.86 - $29.09 $11 Million - $16.1 Million	552,238 Added 15.12%	4,204,979 $95.7 Million
Q1 2024 May 14, 2024	BUY	$28.21 - $37.78 $7.3 Million - $9.77 Million	258,705 Added 7.62%	3,652,741 $111 Million
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $5.5 Million - $7.22 Million	166,827 Added 5.17%	3,394,036 $121 Million
Q3 2023 Nov 14, 2023	BUY	$41.12 - $57.73 $708,086 - $994,110	17,220 Added 0.54%	3,227,209 $141 Million
Q2 2023 Aug 15, 2023	BUY	$40.44 - $49.6 $3.5 Million - $4.29 Million	86,485 Added 2.77%	3,209,989 $158 Million
Q1 2023 May 15, 2023	SELL	$35.87 - $47.22 $15.9 Million - $20.9 Million	-442,222 Reduced 12.4%	3,123,504 $129 Million
Q4 2022 Feb 14, 2023	SELL	$33.48 - $47.45 $16.2 Million - $22.9 Million	-483,097 Reduced 11.93%	3,565,726 $158 Million
Q3 2022 Nov 15, 2022	BUY	$38.25 - $52.62 $1.78 Million - $2.45 Million	46,474 Added 1.16%	4,048,823 $158 Million
Q2 2022 Aug 15, 2022	BUY	$35.1 - $66.01 $6.67 Million - $12.5 Million	189,935 Added 4.98%	4,002,349 $164 Million
Q1 2022 May 13, 2022	BUY	$57.43 - $71.39 $20.5 Million - $25.5 Million	356,558 Added 10.32%	3,812,414 $250 Million
Q4 2021 Feb 14, 2022	BUY	$63.4 - $87.14 $34.5 Million - $47.4 Million	544,296 Added 18.69%	3,455,856 $240 Million
Q3 2021 Nov 10, 2021	BUY	$69.28 - $84.46 $5.54 Million - $6.76 Million	80,022 Added 2.83%	2,911,560 $202 Million
Q2 2021 Jul 30, 2021	BUY	$64.13 - $80.18 $24.8 Million - $31 Million	387,101 Added 15.84%	2,831,538 $225 Million
Q1 2021 May 06, 2021	BUY	$53.79 - $66.98 $128 Million - $160 Million	2,381,637 Added 3792.42%	2,444,437 $160 Million
Q4 2020 Feb 08, 2021	BUY	$34.56 - $57.55 $152,064 - $253,220	4,400 Added 7.53%	62,800 $3.5 Million
Q3 2020 Nov 12, 2020	SELL	$38.36 - $46.91 $122,752 - $150,112	-3,200 Reduced 5.19%	58,400 $2.33 Million
Q2 2020 Aug 13, 2020	BUY	$31.78 - $51.19 $117,586 - $189,403	3,700 Added 6.39%	61,600 $2.77 Million
Q1 2020 May 14, 2020	BUY	$24.49 - $43.84 $41,633 - $74,528	1,700 Added 3.02%	57,900 $1.95 Million
Q2 2019 Aug 14, 2019	BUY	$26.85 - $30.74 $349,050 - $399,620	13,000 Added 30.09%	56,200 $1.68 Million
Q2 2018 Aug 13, 2018	BUY	$19.65 - $30.28 $27,509 - $42,392	1,400 Added 3.35%	43,200 $1.17 Million
Q4 2017 Feb 13, 2018	SELL	$17.69 - $23.44 $51,301 - $67,976	-2,900 Reduced 6.49%	41,800 $762,000
Q3 2017 Nov 13, 2017	BUY	$20.0 - $24.23 $894,000 - $1.08 Million	44,700	44,700 $1 Million

Others Institutions Holding ATRC

# of Institutions

236

Shares Held

51.9M

Call Options Held

32.6K

Put Options Held

4.5K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.36B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Atri Cure, Inc. Transaction History